New targeted drug PLB-002 enters human trials for Hard-to-Treat cancers
Disease control
Recruiting now
This early-phase study tests a new drug called PLB-002 in about 100 adults with advanced solid tumors (cancers that have spread). The drug is designed to target a protein (Claudin 6) found on some cancer cells. The main goals are to find a safe dose and understand side effects. T…
Phase: PHASE1 • Sponsor: Primelink BioTherapeitics(ShenZhen) Limited • Aim: Disease control
Last updated May 26, 2026 10:39 UTC